Please login to the form below

Not currently logged in
Email:
Password:

Vifor Pharma appoints Dario Eklund

He takes on the role of head of international business operations

edit-Dario-EklundVifor Pharma has named Dario Eklund as their head of international business operations.

Eklund joins from Organogenesis, a regenerative medicine company which focuses in wound healing and soft tissue regeneration, where he was VP with responsibility for non-US operations, business development and licensing and the Gintuit business unit.

Prior to that, he was general manager of Switzerland for Aventis Pharma, until its 2004 merger with Sanofi, and earlier in his career he held a number of commercial and management roles for Novartis.

Eklund will report directly to Vifor Pharma CEO Søren Tulstrup and will be based at company's headquarters in Zurich, Switzerland.

Meanwhile, Vifor has also appointed Abdul Mullick to the position of head of global marketing. His previous roles include VP and general manager of endocrinology and cardiology in the rare diseases division of Sanofi in Boston, where he led the US and international operations.

18th September 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics